CARRIE ROBISON: Open Payments
NPI 1548789118 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 88 payments from 15 companies in 2025. Trend: 2023 $1,631 · 2024 $3,537 · 2025 $1,284
Food & beverage: $1,284
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $525 |
| Novartis Pharmaceuticals Corporation | 10 | $210 |
| Neurocrine BioSciences, Inc. | 11 | $135 |
| PFIZER INC. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
| Impel Pharmaceuticals LLC | 3 | $49 |
| SK Life Science, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| UCB, Inc. | 1 | $24 |
Products named: UBRELVY, KESIMPTA, QULIPTA, INGREZZA, NURTEC ODT, PONVORY, TRUDHESA, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
